$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 14 15 16 17 18 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 72.51 | 33 | 2,393 | 5,000 | 5 K to 5 K (-0.66 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 72.50 | 20 | 1,450 | 5,033 | 5.1 K to 5 K (-0.40 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 3,000 | 19,500 | 35,750 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 73.51 | 613 | 45,062 | 5,577 | 6.2 K to 5.6 K (-9.90 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 73.50 | 1,628 | 119,658 | 6,190 | 7.8 K to 6.2 K (-20.82 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 73.42 | 350 | 25,698 | 7,818 | 8.2 K to 7.8 K (-4.29 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 72.93 | 102 | 7,438 | 8,168 | 8.3 K to 8.2 K (-1.23 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 72.62 | 56 | 4,067 | 8,270 | 8.3 K to 8.3 K (-0.67 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 72.55 | 53 | 3,845 | 8,326 | 8.4 K to 8.3 K (-0.63 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 72.51 | 145 | 10,515 | 8,379 | 8.5 K to 8.4 K (-1.70 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 72.50 | 53 | 3,843 | 8,524 | 8.6 K to 8.5 K (-0.62 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 3,000 | 19,500 | 8,577 | 5.6 K to 8.6 K (+53.79 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 4.25 | 6,675 | 28,369 | 2,650 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.51 | 1,363 | 100,196 | 34,199 | 35.6 K to 34.2 K (-3.83 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.50 | 3,622 | 266,217 | 35,562 | 39.2 K to 35.6 K (-9.24 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.42 | 779 | 57,197 | 39,184 | 40 K to 39.2 K (-1.95 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 72.93 | 234 | 17,064 | 39,963 | 40.2 K to 40 K (-0.58 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 72.62 | 117 | 8,497 | 40,197 | 40.3 K to 40.2 K (-0.29 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 72.55 | 117 | 8,488 | 40,314 | 40.4 K to 40.3 K (-0.29 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 72.51 | 237 | 17,186 | 40,431 | 40.7 K to 40.4 K (-0.58 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 72.50 | 206 | 14,935 | 40,668 | 40.9 K to 40.7 K (-0.50 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 4.25 | 6,675 | 28,369 | 40,874 | 34.2 K to 40.9 K (+19.52 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 6,063 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 73.51 | 95 | 6,984 | 0 | 95 to 0 (-100.00 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 73.50 | 253 | 18,596 | 95 | 348 to 95 (-72.70 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 73.42 | 54 | 3,965 | 348 | 402 to 348 (-13.43 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 72.93 | 20 | 1,459 | 402 | 422 to 402 (-4.74 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 72.62 | 4 | 290 | 422 | 426 to 422 (-0.94 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 72.55 | 8 | 580 | 426 | 434 to 426 (-1.84 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 72.51 | 32 | 2,320 | 434 | 466 to 434 (-6.87 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 72.50 | 1 | 73 | 466 | 467 to 466 (-0.21 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 4,000 | 86,200 | 10,760 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 82.30 | 820 | 67,490 | 0 | 820 to 0 (-100.00 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 81.61 | 515 | 42,027 | 820 | 1.3 K to 820 (-38.58 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.90 | 499 | 40,369 | 1,335 | 1.8 K to 1.3 K (-27.21 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.70 | 1,998 | 161,239 | 1,834 | 3.8 K to 1.8 K (-52.14 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.50 | 168 | 13,524 | 3,832 | 4 K to 3.8 K (-4.20 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 4,000 | 86,200 | 4,000 | 0 to 4 K |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 4,000 | 86,200 | 10,760 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 82.30 | 820 | 67,490 | 0 | 820 to 0 (-100.00 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 81.61 | 515 | 42,027 | 820 | 1.3 K to 820 (-38.58 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.90 | 499 | 40,369 | 1,335 | 1.8 K to 1.3 K (-27.21 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.70 | 1,998 | 161,239 | 1,834 | 3.8 K to 1.8 K (-52.14 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 80.50 | 168 | 13,524 | 3,832 | 4 K to 3.8 K (-4.20 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 4,000 | 86,200 | 4,000 | 0 to 4 K |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 1,250 | 11,250 | 10,655 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 82.30 | 255 | 20,988 | 4,766 | 5 K to 4.8 K (-5.08 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.61 | 162 | 13,220 | 5,021 | 5.2 K to 5 K (-3.13 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.90 | 156 | 12,620 | 5,183 | 5.3 K to 5.2 K (-2.92 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.70 | 630 | 50,841 | 5,339 | 6 K to 5.3 K (-10.55 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.50 | 47 | 3,784 | 5,969 | 6 K to 6 K (-0.78 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 1,250 | 11,250 | 6,016 | 4.8 K to 6 K (+26.23 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 14,358 | 309,415 | 11,160 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 45.01 | 20,000 | 900,200 | 130,000 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 82.30 | 7,038 | 579,262 | 4,255 | 11.3 K to 4.3 K (-62.32 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.61 | 4,429 | 361,436 | 11,293 | 15.7 K to 11.3 K (-28.17 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 80.90 | 4,291 | 347,142 | 15,722 | 20 K to 15.7 K (-21.44 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 80.70 | 17,167 | 1,385,377 | 20,013 | 37.2 K to 20 K (-46.17 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 80.50 | 1,433 | 115,357 | 37,180 | 38.6 K to 37.2 K (-3.71 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 14,358 | 309,415 | 38,613 | 24.3 K to 38.6 K (+59.20 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 45.01 | 20,000 | 900,200 | 24,255 | 4.3 K to 24.3 K (+470.04 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 9.00 | 20,000 | 180,000 | 0 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 82.30 | 4,098 | 337,285 | 5,577 | 9.7 K to 5.6 K (-42.36 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.61 | 2,577 | 210,300 | 9,675 | 12.3 K to 9.7 K (-21.03 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.90 | 2,499 | 202,169 | 12,252 | 14.8 K to 12.3 K (-16.94 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.70 | 9,987 | 805,951 | 14,751 | 24.7 K to 14.8 K (-40.37 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.50 | 839 | 67,540 | 24,738 | 25.6 K to 24.7 K (-3.28 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 9.00 | 20,000 | 180,000 | 25,577 | 5.6 K to 25.6 K (+358.62 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 9.00 | 20,000 | 180,000 | 0 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 82.30 | 4,098 | 337,285 | 5,577 | 9.7 K to 5.6 K (-42.36 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.61 | 2,577 | 210,300 | 9,675 | 12.3 K to 9.7 K (-21.03 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.90 | 2,499 | 202,169 | 12,252 | 14.8 K to 12.3 K (-16.94 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.70 | 9,987 | 805,951 | 14,751 | 24.7 K to 14.8 K (-40.37 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 80.50 | 839 | 67,540 | 24,738 | 25.6 K to 24.7 K (-3.28 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 9.00 | 20,000 | 180,000 | 25,577 | 5.6 K to 25.6 K (+358.62 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 48.00 | 40,000 | 1,920,000 | 0 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 6,530 | |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 82.30 | 8,289 | 682,225 | 0 | 8.3 K to 0 (-100.00 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.61 | 5,217 | 425,742 | 8,289 | 13.5 K to 8.3 K (-38.63 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 80.90 | 5,055 | 408,950 | 13,506 | 18.6 K to 13.5 K (-27.23 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 80.70 | 20,218 | 1,631,593 | 18,561 | 38.8 K to 18.6 K (-52.14 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 80.50 | 1,688 | 135,884 | 38,779 | 40.5 K to 38.8 K (-4.17 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 48.00 | 40,000 | 1,920,000 | 40,467 | 467 to 40.5 K (+8,565.31 %) |
Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 833 | 7,497 | 11,905 | |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 40.00 | 833 | 33,320 | 4,766 | 5.6 K to 4.8 K (-14.88 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 833 | 7,497 | 5,599 | 4.8 K to 5.6 K (+17.48 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 1,250 | 8,125 | 38,750 | |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 40.00 | 1,250 | 50,000 | 5,577 | 6.8 K to 5.6 K (-18.31 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 1,250 | 8,125 | 6,827 | 5.6 K to 6.8 K (+22.41 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 4.25 | 6,675 | 28,369 | 9,325 | |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 40.00 | 6,675 | 267,000 | 34,199 | 40.9 K to 34.2 K (-16.33 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 4.25 | 6,675 | 28,369 | 40,874 | 34.2 K to 40.9 K (+19.52 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 4.25 | 6,675 | 28,369 | 9,325 | |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 40.00 | 6,675 | 267,000 | 34,199 | 40.9 K to 34.2 K (-16.33 %) |
Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 4.25 | 6,675 | 28,369 | 40,874 | 34.2 K to 40.9 K (+19.52 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 1,000 | 21,550 | 14,760 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.34 | 43 | 1,649 | 0 | 43 to 0 (-100.00 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.33 | 47 | 1,802 | 43 | 90 to 43 (-52.22 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.30 | 330 | 12,639 | 90 | 420 to 90 (-78.57 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.25 | 76 | 2,907 | 420 | 496 to 420 (-15.32 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.24 | 427 | 16,328 | 496 | 923 to 496 (-46.26 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.23 | 22 | 841 | 923 | 945 to 923 (-2.33 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.20 | 52 | 1,986 | 945 | 997 to 945 (-5.22 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 38.18 | 3 | 115 | 997 | 1,000 to 997 (-0.30 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 1,000 | 21,550 | 1,000 | 0 to 1,000 |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 25,518 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.34 | 34 | 1,304 | 4,255 | 4.3 K to 4.3 K (-0.79 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.33 | 38 | 1,457 | 4,289 | 4.3 K to 4.3 K (-0.88 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.30 | 262 | 10,035 | 4,327 | 4.6 K to 4.3 K (-5.71 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.25 | 63 | 2,410 | 4,589 | 4.7 K to 4.6 K (-1.35 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.24 | 341 | 13,040 | 4,652 | 5 K to 4.7 K (-6.83 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.23 | 17 | 650 | 4,993 | 5 K to 5 K (-0.34 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.20 | 41 | 1,566 | 5,010 | 5.1 K to 5 K (-0.81 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 38.18 | 2 | 76 | 5,051 | 5.1 K to 5.1 K (-0.04 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 42,750 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.34 | 63 | 2,415 | 2,890 | 3 K to 2.9 K (-2.13 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.33 | 69 | 2,645 | 2,953 | 3 K to 3 K (-2.28 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.30 | 476 | 18,231 | 3,022 | 3.5 K to 3 K (-13.61 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.25 | 112 | 4,284 | 3,498 | 3.6 K to 3.5 K (-3.10 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.24 | 620 | 23,709 | 3,610 | 4.2 K to 3.6 K (-14.66 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.23 | 31 | 1,185 | 4,230 | 4.3 K to 4.2 K (-0.73 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.20 | 75 | 2,865 | 4,261 | 4.3 K to 4.3 K (-1.73 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 38.18 | 4 | 153 | 4,336 | 4.3 K to 4.3 K (-0.09 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 4,340 | 2.9 K to 4.3 K (+50.17 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 667 | 6,003 | 12,738 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.34 | 29 | 1,112 | 4,766 | 4.8 K to 4.8 K (-0.60 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.33 | 32 | 1,227 | 4,795 | 4.8 K to 4.8 K (-0.66 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.30 | 218 | 8,349 | 4,827 | 5 K to 4.8 K (-4.32 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.25 | 52 | 1,989 | 5,045 | 5.1 K to 5 K (-1.02 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.24 | 285 | 10,898 | 5,097 | 5.4 K to 5.1 K (-5.30 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.23 | 14 | 535 | 5,382 | 5.4 K to 5.4 K (-0.26 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.20 | 35 | 1,337 | 5,396 | 5.4 K to 5.4 K (-0.64 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.18 | 2 | 76 | 5,431 | 5.4 K to 5.4 K (-0.04 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 667 | 6,003 | 5,433 | 4.8 K to 5.4 K (+13.99 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Option Exercise | M | 21.55 | 5,500 | 118,525 | 7,834 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.34 | 237 | 9,087 | 0 | 237 to 0 (-100.00 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.33 | 262 | 10,042 | 237 | 499 to 237 (-52.51 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.30 | 1,804 | 69,093 | 499 | 2.3 K to 499 (-78.33 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.25 | 428 | 16,371 | 2,303 | 2.7 K to 2.3 K (-15.67 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.24 | 2,350 | 89,864 | 2,731 | 5.1 K to 2.7 K (-46.25 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.23 | 119 | 4,549 | 5,081 | 5.2 K to 5.1 K (-2.29 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.20 | 285 | 10,887 | 5,200 | 5.5 K to 5.2 K (-5.20 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 38.18 | 15 | 573 | 5,485 | 5.5 K to 5.5 K (-0.27 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Buy | M | 21.55 | 5,500 | 118,525 | 5,500 | 0 to 5.5 K |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 1,750 | 11,375 | 40,000 | |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.34 | 76 | 2,914 | 5,577 | 5.7 K to 5.6 K (-1.34 %) |